Carbon-Ion Radiotherapy for Oral Non-Squamous Cell Carcinoma: Clinical and Radiophysical Perspectives for Indonesia
DOI:
https://doi.org/10.23960/jemit.442Keywords:
Keywords : carbon-ion radiotherapy, oral non-SCC, radioresistant tumor, medical physics, IndonesiaAbstract
Oral non-squamous cell carcinoma (non-SCC) represents a radioresistant malignancy that often responds poorly to conventional X-ray radiotherapy. This resistance creates major clinical challenges, especially in resource-limited settings such as Indonesia. Carbon-ion radiotherapy (C-ion RT) has emerged as an advanced treatment modality that offers superior dose distribution and higher biological effectiveness, making it particularly promising for tumors that are refractory to photon therapy. A systematic narrative review was conducted following the PRISMA 2020 framework. Literature searches in PubMed, Scopus, and ScienceDirect (January 2013-June 2024) used the terms "carbon-ion radiotherapy," "oral cancer," "non-squamous cell carcinoma," "clinical outcome," and "toxicity." Studies reporting quantitative data on treatment outcomes were included and analyzed descriptively from both clinical and medical physics perspectives. Thirty-two eligible studies were reviewed, including data from Japan, Germany, and Italy. Across these cohorts, C-ion RT achieved a mean 5-year local control rate of 78.8% and an overall survival rate of 58.3%, outperforming conventional X-ray radiotherapy and demonstrating superiority over proton therapy in biological effectiveness (RBE about 2-3). The dominant acute toxicity was mild-to-moderate oral mucositis (about 28%, grade 1-2), while late osteoradionecrosis occurred in 10-14% of cases but was largely manageable with conservative care. C-ion RT offers a unique combination of physical precision and biological potency that makes it highly effective for radioresistant oral cancers. For Indonesia, its gradual implementation, supported by international collaboration, workforce training, and national policy integration, could enhance cancer treatment capacity and stimulate innovation in medical physics and radiotherapy technology. This review also discusses the strategic readiness for integrating C-ion RT into Indonesia's healthcare system.
Downloads
References
Badan Pengawas Tenaga Nuklir. (2013). Peraturan Kepala BAPETEN No. 4 Tahun 2013 tentang proteksi radiasi dan keselamatan radiasi pada medis. BAPETEN.
Badan Riset dan Inovasi Nasional. (2024). Agenda riset prioritas nasional 2025: Ketahanan kesehatan dan teknologi radiasi lanjut. BRIN.
Beltran, C., & Snyder, M. (2018). Development of radiotherapy infrastructure in low- and middle-income countries. Physica Medica, 52, 12–18.
Cleary, M., et al. (2017). Functional outcomes and quality of life following oral cancer therapy. Journal of Oral and Maxillofacial Surgery, 75(3), 520–528.
Durante, M., & Loeffler, J. S. (2010). Charged particles in radiation oncology. Nature Reviews Clinical Oncology, 7, 37–43.
Friedrich, T., et al. (2013). Calculation of the biological effectiveness of ion beams based on the local effect model. Radiation Research, 180(5), 485–495.
Hayashi, K., Koto, M., Ikawa, T., et al. (2021). Clinical outcomes of carbon-ion radiotherapy for head and neck malignancies. Radiotherapy and Oncology, 160, 66–73.
Heidelberg Ion-Beam Therapy Center. (2023). Clinical results and research highlights 2022. Heidelberg University Hospital.
Ikawa, T., Koto, M., Hayashi, K., et al. (2019). Carbon-ion radiotherapy for oral non-squamous cell carcinoma. Oral Oncology, 98, 72–78.
International Atomic Energy Agency. (2018). Radiation protection and safety in medical uses of ionizing radiation (Safety Standards Series No. SSG-46). IAEA.
International Atomic Energy Agency. (2023). Directory of Radiotherapy Centres (DIRAC) 2023 edition. IAEA.
International Agency for Research on Cancer. (2023). GLOBOCAN 2022: Cancer incidence, mortality and prevalence worldwide. IARC.
International Organization for Medical Physics. (2021). Status of medical-physics workforce in low- and middle-income countries. Medical Physics International, 9(1), 15–22.
Jensen, A. D., et al. (2020). Carbon-ion radiotherapy for head and neck adenoid cystic carcinoma: Clinical results and patterns of failure. Cancers, 12(10), Article 2863.
Kamada, T., Kato, S., & Tsujii, H. (2018). Carbon-ion radiotherapy in Japan: Achievements and future directions. The Lancet Oncology, 19, e316–e325.
Kanai, T., et al. (2011). Design and characteristics of the HIMAC accelerator complex for heavy-ion cancer therapy. Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms, 269, 325–331.
Kase, Y., et al. (2006). Microdosimetric measurements and estimation of relative biological effectiveness of carbon-ion beams at HIMAC. Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms, 245, 85–94.
Kementerian Kesehatan Republik Indonesia. (2020). Rencana aksi nasional pengendalian kanker (RAN-P) 2020–2025. Kementerian Kesehatan Republik Indonesia.
Kementerian Kesehatan Republik Indonesia. (2022). Profil kesehatan Indonesia 2022. Kementerian Kesehatan Republik Indonesia.
Koto, M., et al. (2017). Clinical experience with carbon-ion radiotherapy for head and neck malignancies at NIRS. Radiotherapy and Oncology, 123(3), 387–392.
Matsunobu, A., et al. (2012). Impact of carbon-ion radiotherapy on locally advanced head and neck cancers. International Journal of Radiation Oncology, Biology, Physics, 83(2), 762–768.
National Center for Oncological Hadrontherapy. (2022). Scientific activity report 2021–2022. CNAO Foundation.
National Institute of Radiological Sciences. (2021). Annual report on Heavy-Ion Medical Accelerator in Chiba (HIMAC). NIRS.
Ohnishi, K., Okonogi, N., Ohno, T., & Nakano, T. (2020). Comparative outcomes of carbon-ion radiotherapy and proton therapy for head and neck malignancies. International Journal of Radiation Oncology, Biology, Physics, 108(2), 422–430. https://doi.org/10.1016/j.ijrobp.2020.06.046
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., et al. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, n71. https://doi.org/10.1136/bmj.n71
Shirai, K., Saitoh, J., Musha, A., Abe, T., & Kamada, T. (2022). Osteoradionecrosis after carbon-ion radiotherapy for head and neck tumors. Radiotherapy and Oncology, 170, 127–133. https://doi.org/10.1016/j.radonc.2022.03.015
Tsujii, H. (2012). Overview of HIMAC and the future of heavy-ion radiotherapy. Journal of Radiation Research, 53(Suppl. 1), i1–i4.
Tsujii, H., & Kamada, T. (2012). A review of carbon-ion radiotherapy. Radiotherapy and Oncology, 105, 2–7.
Vanderstraeten, B., et al. (2022). Global access to radiotherapy: Status and challenges. Clinical and Translational Radiation Oncology, 34, 62–69.
World Health Organization. (2022). Radiotherapy resources: Global Health Observatory data. WHO.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026
This work is licensed under a Creative Commons Attribution 4.0 International License.
